LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Revenue History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
What is the latest Revenue of LASA SUPERGENERICS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹104 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹202 Cr |
| Mar2020 | ₹167 Cr |
How is Revenue of LASA SUPERGENERICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -19.47 | |
| Mar2023 | ₹130 Cr | -5.51 | |
| Mar2022 | ₹137 Cr | -32.24 | |
| Mar2021 | ₹202 Cr | 21.00 | |
| Mar2020 | ₹167 Cr | - | |
Compare Revenue of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹53.9 Cr | -7.9% | -3.9% | -60.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,738.0 Cr | 1.4% | 3.5% | -5.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,067.0 Cr | -3.9% | 6.6% | 15.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,476.0 Cr | 7% | 7.8% | 19.8% | Stock Analytics | |
| CIPLA | ₹122,773.0 Cr | 0.8% | 0.2% | -5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,595.0 Cr | 0.9% | -2.8% | -5.8% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -7.9% |
-3.9% |
-60.4% |
| SENSEX | -0.1% |
2.6% |
6.5% |
You may also like the below Video Courses